United Bank (Virginia)’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-37,400
Closed -$7K 170
2022
Q3
$7K Buy
37,400
+10,500
+39% +$1.97K ﹤0.01% 157
2022
Q2
$16K Hold
26,900
﹤0.01% 146
2022
Q1
$36K Buy
+26,900
New +$36K ﹤0.01% 158